These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7537609)

  • 1. Peripheral blood progenitor cell transplantation: clinical, practical, and economic considerations. Symposium held at the London Regional Cancer Centre, London, Ontario, Canada, November 1993.
    Smith AM; Keating A
    J Hematother; 1994; 3(4):331-48. PubMed ID: 7537609
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid and sustained allogeneic transplantation using immunoselected CD34(+)-selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony-stimulating factors.
    Corringham RE; Ho AD
    Blood; 1995 Sep; 86(5):2052-4. PubMed ID: 7544651
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral blood progenitor cell (PBPC) transplantation with a single apheresis in various malignancies.
    Efremidis AP; Koumakis G; Filis J; Moraki M; Vassilomanolakis M; Barbounis V; Hatzichristou H; Papanastasiou K; Stamatellou M
    Bone Marrow Transplant; 1996 Apr; 17(4):673-4. PubMed ID: 8722374
    [No Abstract]   [Full Text] [Related]  

  • 4. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood progenitor cells: a replacement for marrow transplantation?
    Champlin RE
    Semin Oncol; 1996 Apr; 23(2 Suppl 4):15-21. PubMed ID: 8600543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
    J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic transplantation of peripheral blood progenitor cells.
    Link H; Arseniev L
    Ann Oncol; 1996; 7 Suppl 2():41-5. PubMed ID: 8805948
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factors.
    Handgretinger R; Klingebiel T; Herter M; Lang P; Gisselhart A; Dopfer R; Scheel-Walter H; Ehrlich H; Niethammer D
    Prog Clin Biol Res; 1994; 389():479-86. PubMed ID: 7535457
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral blood progenitor cells for HPC transplants involving unrelated donors.
    Stroncek DF; Confer DL; Leitman SF
    Transfusion; 2000 Jun; 40(6):731-41. PubMed ID: 10864997
    [No Abstract]   [Full Text] [Related]  

  • 10. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.
    Akabutu JJ; Chan JR
    Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral blood stem cell mobilization after stem cell factor or G-CSF treatment: rapid enrichment for stem and progenitor cells using the CEPRATE immunoaffinity separation system.
    Heimfeld S; Fogarty B; McGuire K; Williams S; Berenson RJ
    Transplant Proc; 1992 Dec; 24(6):2818. PubMed ID: 1281575
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor.
    Suzue T; Kawano Y; Takaue Y; Kuroda Y
    Exp Hematol; 1994 Aug; 22(9):888-92. PubMed ID: 7520392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
    Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
    Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
    Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis.
    Kerst JM; Slaper-Cortenbach IC; von dem Borne AE; van der Schoot CE; van Oers RH
    Exp Hematol; 1992 Nov; 20(10):1188-93. PubMed ID: 1385196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of peripheral blood CD34+ progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor.
    Teofili L; Iovino MS; Sica S; Pierelli L; Menichella G; De Stefano V; Rumi C; Leone G
    Exp Hematol; 1994 Sep; 22(10):990-5. PubMed ID: 7522187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.